Published in Women's Health Weekly, June 9th, 2005
"Women with HER-2 positive breast cancer had a high risk of the cancer returning and of dying from breast cancer. This intervention - chemotherapy plus trastuzumab - essentially...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly